NITTA GELATIN INCNN

NITTA GELATIN INC

734JPYD
−5−0.68%
At close at 06:25 UTC
JPY
No trades
See on Supercharts

4977 fundamentals

Key facts

Market capitalization‪13.33 B‬JPY
Basic EPS (TTM)−94.72JPY
Founded1918
CEO
About

Nitta Gelatin, Inc. engages in the production and sale of gelatin and collagen-related products. It operates through the following divisions Collagen Materials Business and Formula Solutions Business. The Collagen Materials Business division manufactures and sells gelatin, collagen peptide, collagen casing, collagen and other products made from animal bones and skin or fish scales and fish skin. The Formula Solutions Business division manufactures and sells food formulations such as edible gelling agents and quality stabilizers that are used in confectionery, desserts, delicatessen items, and chilled foods, as well as hot-melt adhesives that are used for packaging, bookbinding, and others. It also engages in the production and sale of adhesives for packaging, bookbinding, building materials and hygiene products. The company was founded by Chojiro Nitta in January 1918 and is headquartered in Osaka, Japan.

Ownership
‪‪18.17 M‬‬
Free Float shares
‪‪10.31 M‬‬ (56.75%)
Closely held shares
‪‪7.86 M‬‬ (43.25%)
Free Float shares
‪‪10.31 M‬‬ (56.75%)
Closely held shares
‪‪7.86 M‬‬ (43.25%)
Capital structure
Market cap
‪‪13.33 B‬‬
Debt
‪‪8.38 B‬‬
Minority interest
‪‪4.14 B‬‬
Cash & equivalents
‪‪4.65 B‬‬
Enterprise value
‪‪21.20 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪13.33 B‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
0.33x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
0.33x
Valuation ratios
‪0.00‬
‪0.10‬
‪0.20‬
‪0.30‬
‪0.40‬
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
‪2.50‬
‪5.00‬
‪7.50‬
‪10.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−24%‬
‪−16%‬
‪−8%‬
‪0%‬
‪8%‬
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪‪−4.00 B‬‬
‪0.00‬
‪‪4.00 B‬‬
‪‪8.00 B‬‬
‪‪12.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪2.50 B‬‬
‪‪5.00 B‬‬
‪‪7.50 B‬‬
‪‪10.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪2.50 B‬‬
‪‪5.00 B‬‬
‪‪7.50 B‬‬
‪‪10.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Health Support
Food Solutions
Specialty
By country
Period: 2023
Japan
United States
India
Asia
Canada
Other

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪3.00 B‬‬
‪‪6.00 B‬‬
‪‪9.00 B‬‬
‪‪12.00 B‬‬
Actual
Estimate
Earnings
Next:Feb 17
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪−135.00‬
‪−90.00‬
‪−45.00‬
‪0.00‬
‪45.00‬
Actual

Dividends

Dividend yield, history and sustainability

Dividend summary
−17.95%
Payout ratio (TTM)
Dividend yield TTM
2.31%
Next payment
9.00
Next ex-date
Mar 28, 2025
Dividend history
‪1.5%‬
‪1.7%‬
‪1.9%‬
‪2.1%‬
‪2.3%‬
2019
2020
2021
2022
2023
‪0.00‬
‪4.00‬
‪8.00‬
‪12.00‬
‪16.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
‪‪3.00 B‬‬
‪‪6.00 B‬‬
‪‪9.00 B‬‬
‪‪12.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪7.00 B‬‬
‪‪14.00 B‬‬
‪‪21.00 B‬‬
‪‪28.00 B‬‬
Assets
Liabilities